{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,19]],"date-time":"2026-01-19T04:28:44Z","timestamp":1768796924574,"version":"3.49.0"},"reference-count":135,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2017,4,1]],"date-time":"2017-04-01T00:00:00Z","timestamp":1491004800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2017,4,1]],"date-time":"2017-04-01T00:00:00Z","timestamp":1491004800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2017,1,12]],"date-time":"2017-01-12T00:00:00Z","timestamp":1484179200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"name":"Osteoporosis Foundation of New Mexico"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Clinical Densitometry"],"published-print":{"date-parts":[[2017,4]]},"DOI":"10.1016\/j.jocd.2017.01.001","type":"journal-article","created":{"date-parts":[[2017,2,6]],"date-time":"2017-02-06T20:31:36Z","timestamp":1486413096000},"page":"134-152","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":13,"title":["Proceedings of the 2016 Santa Fe Bone Symposium: New Concepts in the Management of Osteoporosis and Metabolic Bone Diseases"],"prefix":"10.1016","volume":"20","author":[{"given":"E. Michael","family":"Lewiecki","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"John P.","family":"Bilezikian","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Susan V.","family":"Bukata","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pauline","family":"Camacho","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bart L.","family":"Clarke","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael R.","family":"McClung","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paul D.","family":"Miller","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"John","family":"Shepherd","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jocd.2017.01.001_bib0010","doi-asserted-by":"crossref","first-page":"825","DOI":"10.2217\/17455057.2.6.825","article-title":"Proceedings of the Santa Fe Bone Symposium 2006","volume":"2","author":"Lewiecki","year":"2006","journal-title":"Womens Health (Lond)"},{"key":"10.1016\/j.jocd.2017.01.001_bib0015","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1016\/j.jocd.2007.12.017","article-title":"Proceedings of the Eighth Annual Santa Fe Bone Symposium, August 3\u20134, 2007","volume":"11","author":"Lewiecki","year":"2008","journal-title":"J Clin Densitom"},{"key":"10.1016\/j.jocd.2017.01.001_bib0020","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/j.jocd.2009.02.002","article-title":"2008 Santa Fe Bone Symposium: update on osteoporosis","volume":"12","author":"Lewiecki","year":"2009","journal-title":"J Clin Densitom"},{"key":"10.1016\/j.jocd.2017.01.001_bib0025","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jocd.2009.12.003","article-title":"2009 Santa Fe Bone Symposium","volume":"13","author":"Lewiecki","year":"2010","journal-title":"J Clin Densitom"},{"key":"10.1016\/j.jocd.2017.01.001_bib0030","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jocd.2010.12.001","article-title":"Osteoporosis update from the 2010 Santa Fe Bone Symposium","volume":"14","author":"Lewiecki","year":"2010","journal-title":"J Clin Densitom"},{"key":"10.1016\/j.jocd.2017.01.001_bib0035","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jocd.2011.11.004","article-title":"Proceedings of the 2011 Santa Fe Bone Symposium","volume":"15","author":"Lewiecki","year":"2012","journal-title":"J Clin Densitom"},{"key":"10.1016\/j.jocd.2017.01.001_bib0040","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1016\/j.jocd.2013.01.001","article-title":"Osteoporosis update from the 2012 Santa Fe Bone Symposium","volume":"16","author":"Lewiecki","year":"2013","journal-title":"J Clin Densitom"},{"key":"10.1016\/j.jocd.2017.01.001_bib0045","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1016\/j.jocd.2013.11.006","article-title":"Osteoporosis update: proceedings of the 2013 Santa Fe Bone Symposium","volume":"17","author":"Lewiecki","year":"2014","journal-title":"J Clin Densitom"},{"key":"10.1016\/j.jocd.2017.01.001_bib0050","doi-asserted-by":"crossref","first-page":"106","DOI":"10.3109\/07435800.2015.1005746","article-title":"Update on osteoporosis from the 2014 Santa Fe Bone Symposium","volume":"40","author":"Lewiecki","year":"2015","journal-title":"Endocr Res"},{"key":"10.1016\/j.jocd.2017.01.001_bib0055","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1016\/j.jocd.2015.11.003","article-title":"Proceedings of the 2015 Santa Fe Bone Symposium: clinical applications of scientific advances in osteoporosis and metabolic bone disease","volume":"19","author":"Lewiecki","year":"2016","journal-title":"J Clin Densitom"},{"key":"10.1016\/j.jocd.2017.01.001_bib0060","unstructured":"Lewiecki E.M., Bilezikian J.P., Miller P.D., et\u00a0al. Highlights from the 2009 Santa Fe Bone Symposium."},{"key":"10.1016\/j.jocd.2017.01.001_bib0065","unstructured":"Lewiecki E.M., Bilezikian J.P., Khosla S., et\u00a0al. Highlights from the 2010 Santa Fe Bone Symposium."},{"key":"10.1016\/j.jocd.2017.01.001_bib0070","unstructured":"Lewiecki E.M., Bilezikian J.P., McCloskey E.V., et\u00a0al. Highlights of the 2011 Santa Fe Bone Symposium."},{"key":"10.1016\/j.jocd.2017.01.001_bib0075","unstructured":"Lewiecki E.M., Bilezikian J.P., Bonewald L.F., et\u00a0al. 2013 Santa Fe Bone Symposium Highlights."},{"key":"10.1016\/j.jocd.2017.01.001_bib0080","unstructured":"Lewiecki E.M., Bilezikian J.P., Binkley N., et\u00a0al. 2014 Santa Fe Bone Symposium Highlights."},{"key":"10.1016\/j.jocd.2017.01.001_bib0085","doi-asserted-by":"crossref","unstructured":"Lewiecki E.M., Bilezikian J.P., Khosla S., et\u00a0al. 2010 Santa Fe Bone Symposium.","DOI":"10.1016\/j.jocd.2009.12.003"},{"key":"10.1016\/j.jocd.2017.01.001_bib0090","unstructured":"Lewiecki E.M., Bilezikian J.P., Miller P.D., et\u00a0al. 2009 Santa Fe Bone Symposium."},{"key":"10.1016\/j.jocd.2017.01.001_bib0095","unstructured":"Lewiecki E.M., Bilezikian J.P., Jankowski L.G., et\u00a0al. 2011 Santa Fe Bone Symposium Highlights."},{"key":"10.1016\/j.jocd.2017.01.001_bib0100","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1016\/j.bone.2011.04.022","article-title":"Bisphosphonates: the first 40 years","volume":"49","author":"Russell","year":"2011","journal-title":"Bone"},{"key":"10.1016\/j.jocd.2017.01.001_bib0105","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1196\/annals.1402.089","article-title":"Bisphosphonates: an update on mechanisms of action and how these relate to clinical efficacy","volume":"1117","author":"Russell","year":"2007","journal-title":"Ann N Y Acad Sci"},{"key":"10.1016\/j.jocd.2017.01.001_bib0110","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1210\/er.2012-1026","article-title":"The osteocyte: an endocrine cell and more","volume":"34","author":"Dallas","year":"2013","journal-title":"Endocr Rev"},{"key":"10.1016\/j.jocd.2017.01.001_bib0115","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1038\/clpt.2011.268","article-title":"Denosumab for the treatment of osteoporosis and cancer-related conditions","volume":"91","author":"Lewiecki","year":"2012","journal-title":"Clin Pharmacol Ther"},{"key":"10.1016\/j.jocd.2017.01.001_bib0120","doi-asserted-by":"crossref","first-page":"2256","DOI":"10.1002\/jbmr.149","article-title":"Effects of denosumab on bone histomorphometry: the FREEDOM and STAND studies","volume":"25","author":"Reid","year":"2010","journal-title":"J Bone Miner Res"},{"key":"10.1016\/j.jocd.2017.01.001_bib0125","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1056\/NEJMoa0809493","article-title":"Denosumab for prevention of fractures in postmenopausal women with osteoporosis","volume":"361","author":"Cummings","year":"2009","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jocd.2017.01.001_bib0130","doi-asserted-by":"crossref","first-page":"2773","DOI":"10.1007\/s00198-015-3234-7","article-title":"The effect of 8 or 5 years of denosumab treatment in postmenopausal women with osteoporosis: results from the FREEDOM Extension study","volume":"26","author":"Papapoulos","year":"2015","journal-title":"Osteoporos Int"},{"key":"10.1016\/j.jocd.2017.01.001_bib0135","first-page":"S32","article-title":"Discontinuation of denosumab and associated fracture incidence: analysis from FREEDOM and its extension","volume":"31","author":"Brown","year":"2016","journal-title":"J Bone Miner Res"},{"key":"10.1016\/j.jocd.2017.01.001_bib0140","doi-asserted-by":"crossref","first-page":"1677","DOI":"10.1007\/s00198-016-3553-3","article-title":"Cancel the denosumab holiday","volume":"27","author":"McClung","year":"2016","journal-title":"Osteoporos Int"},{"key":"10.1016\/j.jocd.2017.01.001_bib0145","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1038\/nrrheum.2011.77","article-title":"Cathepsin K: its skeletal actions and role as a therapeutic target in osteoporosis","volume":"7","author":"Costa","year":"2011","journal-title":"Nat Rev Rheumatol"},{"key":"10.1016\/j.jocd.2017.01.001_bib0150","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.bcp.2016.04.010","article-title":"Pharmacological inhibition of cathepsin K: a promising novel approach for postmenopausal osteoporosis therapy","volume":"117","author":"Mukherjee","year":"2016","journal-title":"Biochem Pharmacol"},{"key":"10.1016\/j.jocd.2017.01.001_bib0155","first-page":"S32","article-title":"The Long-Term Odanacatib Fracture Trial (LOFT): cardiovascular safety results","volume":"31","author":"O'Donoghue","year":"2016","journal-title":"J Bone Miner Res"},{"key":"10.1016\/j.jocd.2017.01.001_bib0160","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1007\/s12020-016-0888-7","article-title":"From disease to treatment: from rare skeletal disorders to treatments for osteoporosis","volume":"52","author":"Appelman-Dijkstra","year":"2016","journal-title":"Endocrine"},{"issue":"Suppl 1","key":"10.1016\/j.jocd.2017.01.001_bib0165","doi-asserted-by":"crossref","first-page":"31","DOI":"10.2106\/JBJS.G.01183","article-title":"Osteocyte-derived sclerostin inhibits bone formation: its role in bone morphogenetic protein and Wnt signaling","volume":"90","author":"ten Dijke","year":"2008","journal-title":"J Bone Joint Surg Am"},{"key":"10.1016\/j.jocd.2017.01.001_bib0170","doi-asserted-by":"crossref","first-page":"1532","DOI":"10.1056\/NEJMoa1607948","article-title":"Romosozumab treatment in postmenopausal women with osteoporosis","volume":"375","author":"Cosman","year":"2016","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jocd.2017.01.001_bib0175","doi-asserted-by":"crossref","first-page":"1434","DOI":"10.1056\/NEJM200105103441904","article-title":"Effect of parathyroid hormone (1\u201334) on fractures and bone mineral density in postmenopausal women with osteoporosis","volume":"344","author":"Neer","year":"2001","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jocd.2017.01.001_bib0180","first-page":"801","article-title":"Catabolic and anabolic actions of parathyroid hormone on the skeleton","volume":"34","author":"Silva","year":"2011","journal-title":"J Endocrinol Invest"},{"key":"10.1016\/j.jocd.2017.01.001_bib0185","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1001\/jama.2016.11136","article-title":"Effect of abaloparatide vs placebo on new vertebral fractures in postmenopausal women with osteoporosis: a randomized clinical trial","volume":"316","author":"Miller","year":"2016","journal-title":"JAMA"},{"key":"10.1016\/j.jocd.2017.01.001_bib0190","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/j.jocd.2016.03.003","article-title":"Best practices for dual-energy x-ray absorptiometry measurement and reporting: International Society for Clinical Densitometry guidance","volume":"19","author":"Lewiecki","year":"2016","journal-title":"J Clin Densitom"},{"key":"10.1016\/j.jocd.2017.01.001_bib0195","doi-asserted-by":"crossref","first-page":"2096","DOI":"10.1056\/NEJMcp1513724","article-title":"Postmenopausal osteoporosis","volume":"374","author":"Black","year":"2016","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jocd.2017.01.001_bib0200","doi-asserted-by":"crossref","first-page":"1485","DOI":"10.1002\/jbmr.2888","article-title":"A crisis in the treatment of osteoporosis","volume":"31","author":"Khosla","year":"2016","journal-title":"J Bone Miner Res"},{"key":"10.1016\/j.jocd.2017.01.001_bib0205","doi-asserted-by":"crossref","first-page":"1959","DOI":"10.1007\/s00198-015-3103-4","article-title":"Inadequate management for secondary fracture prevention in patients with distal radius fracture by trauma surgeons","volume":"26","author":"Baba","year":"2015","journal-title":"Osteoporos Int"},{"key":"10.1016\/j.jocd.2017.01.001_bib0210","doi-asserted-by":"crossref","first-page":"2086","DOI":"10.1002\/jbmr.2559","article-title":"Wrist fracture and risk of subsequent fracture: findings from the Women's Health Initiative Study","volume":"30","author":"Crandall","year":"2015","journal-title":"J Bone Miner Res"},{"key":"10.1016\/j.jocd.2017.01.001_bib0215","doi-asserted-by":"crossref","first-page":"1919","DOI":"10.1007\/s00198-015-3098-x","article-title":"Anti-osteoporosis drug prescribing after hip fracture in the UK: 2000\u20132010","volume":"26","author":"Klop","year":"2015","journal-title":"Osteoporos Int"},{"key":"10.1016\/j.jocd.2017.01.001_bib0220","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1002\/jcb.25266","article-title":"Risks and benefits of bisphosphonate therapies","volume":"117","author":"Reyes","year":"2016","journal-title":"J Cell Biochem"},{"key":"10.1016\/j.jocd.2017.01.001_bib0225","doi-asserted-by":"crossref","first-page":"i3365","DOI":"10.1136\/bmj.i3365","article-title":"Risk of hip, subtrochanteric, and femoral shaft fractures among mid and long term users of alendronate: nationwide cohort and nested case-control study","volume":"353","author":"Abrahamsen","year":"2016","journal-title":"BMJ"},{"key":"10.1016\/j.jocd.2017.01.001_bib0230","doi-asserted-by":"crossref","first-page":"1535","DOI":"10.1016\/S0140-6736(96)07088-2","article-title":"Randomised trial of effect of alendronate on risk of fracture in women with existing vertebral fractures","volume":"348","author":"Black","year":"1996","journal-title":"Lancet"},{"key":"10.1016\/j.jocd.2017.01.001_bib0235","doi-asserted-by":"crossref","first-page":"2077","DOI":"10.1001\/jama.280.24.2077","article-title":"Effect of alendronate on risk of fracture in women with low bone density but without vertebral fractures: results from the Fracture Intervention Trial","volume":"280","author":"Cummings","year":"1998","journal-title":"JAMA"},{"key":"10.1016\/j.jocd.2017.01.001_bib0240","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1002\/jbmr.2708","article-title":"Managing osteoporosis in patients on long-term bisphosphonate treatment: report of a task force of the American Society for Bone and Mineral Research","volume":"31","author":"Adler","year":"2016","journal-title":"J Bone Miner Res"},{"key":"10.1016\/j.jocd.2017.01.001_bib0245","doi-asserted-by":"crossref","first-page":"1758","DOI":"10.1002\/jbmr.2515","article-title":"Higher dietary calcium intakes are associated with reduced risks of fractures, cardiovascular events, and mortality: a prospective cohort study of older men and women","volume":"30","author":"Khan","year":"2015","journal-title":"J Bone Miner Res"},{"key":"10.1016\/j.jocd.2017.01.001_bib0250","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.4158\/EP161435.ESGL","article-title":"American Association of Clinical Endocrinologists and American College of Endocrinology clinical practice guidelines for the diagnosis and treatment of postmenopausal osteoporosis\u20142016\u2014executive summary","volume":"22","author":"Camacho","year":"2016","journal-title":"Endocr Pract"},{"key":"10.1016\/j.jocd.2017.01.001_bib0255","doi-asserted-by":"crossref","first-page":"4431","DOI":"10.1210\/jc.2002-020275","article-title":"Yield of laboratory testing to identify secondary contributors to osteoporosis in otherwise healthy women","volume":"87","author":"Tannenbaum","year":"2002","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.jocd.2017.01.001_bib0260","author":"Hogan"},{"key":"10.1016\/j.jocd.2017.01.001_bib0265","doi-asserted-by":"crossref","first-page":"F1170","DOI":"10.1152\/ajprenal.00072.2005","article-title":"\u201cPhosphatonins\u201d and the regulation of phosphorus homeostasis","volume":"289","author":"Berndt","year":"2005","journal-title":"Am J Physiol Renal Physiol"},{"key":"10.1016\/j.jocd.2017.01.001_bib0270","doi-asserted-by":"crossref","first-page":"9633","DOI":"10.3390\/nu7115492","article-title":"Intakes of calcium and phosphorus and calculated calcium-to-phosphorus ratios of older adults: NHANES 2005\u20132006 data","volume":"7","author":"Adatorwovor","year":"2015","journal-title":"Nutrients"},{"key":"10.1016\/j.jocd.2017.01.001_bib0275","doi-asserted-by":"crossref","first-page":"6","DOI":"10.3945\/ajcn.112.053934","article-title":"Public health impact of dietary phosphorus excess on bone and cardiovascular health in the general population","volume":"98","author":"Calvo","year":"2013","journal-title":"Am J Clin Nutr"},{"key":"10.1016\/j.jocd.2017.01.001_bib0280","author":"Yu"},{"key":"10.1016\/j.jocd.2017.01.001_bib0285","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1097\/RLU.0000000000000500","article-title":"Hyperparathyroidism and hungry bone syndrome revisited","volume":"39","author":"Varma","year":"2014","journal-title":"Clin Nucl Med"},{"key":"10.1016\/j.jocd.2017.01.001_bib0290","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1056\/NEJM196802222780802","article-title":"Evidence for a phosphorus-depletion syndrome in man","volume":"278","author":"Lotz","year":"1968","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jocd.2017.01.001_bib0295","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1007\/s40620-016-0329-y","article-title":"Metabolic diagnosis and medical prevention of calcium nephrolithiasis and its systemic manifestations: a consensus statement","volume":"29","author":"Gambaro","year":"2016","journal-title":"J Nephrol"},{"key":"10.1016\/j.jocd.2017.01.001_bib0300","first-page":"622","article-title":"Multiple spontaneous idiopathic symmetrical fractures","volume":"32","author":"Milkman","year":"1934","journal-title":"Am J Roentgenol"},{"key":"10.1016\/j.jocd.2017.01.001_bib0305","doi-asserted-by":"crossref","first-page":"966","DOI":"10.7326\/0003-4819-89-6-966","article-title":"Osteomalacia: current concepts","volume":"89","author":"Frame","year":"1978","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.jocd.2017.01.001_bib0310","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1002\/jbmr.1805","article-title":"Standardized nomenclature, symbols, and units for bone histomorphometry: a 2012 update of the report of the ASBMR Histomorphometry Nomenclature Committee","volume":"28","author":"Dempster","year":"2013","journal-title":"J Bone Miner Res"},{"key":"10.1016\/j.jocd.2017.01.001_bib0315","doi-asserted-by":"crossref","first-page":"S140","DOI":"10.2215\/CJN.02430508","article-title":"The role of bone biopsy in patients with chronic renal failure","volume":"3","author":"Miller","year":"2008","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1016\/j.jocd.2017.01.001_bib0320","doi-asserted-by":"crossref","first-page":"1260","DOI":"10.1001\/jama.294.10.1260","article-title":"Tumor-induced osteomalacia","volume":"294","author":"Jan de Beur","year":"2005","journal-title":"JAMA"},{"key":"10.1016\/j.jocd.2017.01.001_bib0325","doi-asserted-by":"crossref","first-page":"1381","DOI":"10.1002\/jbmr.340","article-title":"A clinician's guide to X-linked hypophosphatemia","volume":"26","author":"Carpenter","year":"2011","journal-title":"J Bone Miner Res"},{"key":"10.1016\/j.jocd.2017.01.001_bib0330","first-page":"233","article-title":"Inhibition of FGF23 activities as a possible new treatment for patients with FGF23-related hypophosphatemic diseases","volume":"26","author":"Kinoshita","year":"2016","journal-title":"Clin Calcium"},{"key":"10.1016\/j.jocd.2017.01.001_bib0335","doi-asserted-by":"crossref","first-page":"E352","DOI":"10.1210\/jc.2010-0589","article-title":"Circulating levels of soluble klotho and FGF23 in X-linked hypophosphatemia: circadian variance, effects of treatment, and relationship to parathyroid status","volume":"95","author":"Carpenter","year":"2010","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.jocd.2017.01.001_bib0340","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1038\/nrendo.2016.14","article-title":"Hypophosphatasia\u2014aetiology, nosology, pathogenesis, diagnosis and treatment","volume":"12","author":"Whyte","year":"2016","journal-title":"Nat Rev Endocrinol"},{"key":"10.1016\/j.jocd.2017.01.001_bib0345","doi-asserted-by":"crossref","first-page":"941","DOI":"10.4158\/EP15890.OR","article-title":"Adult hypophosphatasia treated with teriparatide: report of 2 patients and review of the literature","volume":"22","author":"Camacho","year":"2016","journal-title":"Endocr Pract"},{"key":"10.1016\/j.jocd.2017.01.001_bib0350","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1586\/17446651.2015.971755","article-title":"PTH(1\u201384) replacement therapy for the treatment of hypoparathyroidism","volume":"10","author":"Cusano","year":"2015","journal-title":"Expert Rev Endocrinol Metab"},{"key":"10.1016\/j.jocd.2017.01.001_bib0355","doi-asserted-by":"crossref","first-page":"2300","DOI":"10.1210\/jc.2015-3909","article-title":"Presentation of hypoparathyroidism: etiologies and clinical features","volume":"101","author":"Shoback","year":"2016","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.jocd.2017.01.001_bib0360","doi-asserted-by":"crossref","first-page":"2317","DOI":"10.1002\/jbmr.483","article-title":"Hypoparathyroidism in the adult: epidemiology, diagnosis, pathophysiology, target-organ involvement, treatment, and challenges for future research","volume":"26","author":"Bilezikian","year":"2011","journal-title":"J Bone Miner Res"},{"key":"10.1016\/j.jocd.2017.01.001_bib0365","doi-asserted-by":"crossref","first-page":"2570","DOI":"10.1002\/jbmr.2004","article-title":"Prevalence and incidence of hypoparathyroidism in the United States using a large claims database","volume":"28","author":"Powers","year":"2013","journal-title":"J Bone Miner Res"},{"key":"10.1016\/j.jocd.2017.01.001_bib0370","doi-asserted-by":"crossref","first-page":"1738","DOI":"10.1002\/jbmr.2501","article-title":"The epidemiology of nonsurgical hypoparathyroidism in Denmark: a nationwide case finding study","volume":"30","author":"Underbjerg","year":"2015","journal-title":"J Bone Miner Res"},{"key":"10.1016\/j.jocd.2017.01.001_bib0375","doi-asserted-by":"crossref","first-page":"2504","DOI":"10.1002\/jbmr.2273","article-title":"Postsurgical hypoparathyroidism\u2014risk of fractures, psychiatric diseases, cancer, cataract, and infections","volume":"29","author":"Underbjerg","year":"2014","journal-title":"J Bone Miner Res"},{"key":"10.1016\/j.jocd.2017.01.001_bib0380","doi-asserted-by":"crossref","first-page":"2284","DOI":"10.1210\/jc.2015-3908","article-title":"Epidemiology and diagnosis of hypoparathyroidism","volume":"101","author":"Clarke","year":"2016","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.jocd.2017.01.001_bib0385","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/S2213-8587(13)70106-2","article-title":"Efficacy and safety of recombinant human parathyroid hormone (1-84) in hypoparathyroidism (REPLACE): a double-blind, placebo-controlled, randomised, phase 3 study","volume":"1","author":"Mannstadt","year":"2013","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/j.jocd.2017.01.001_bib0390","doi-asserted-by":"crossref","first-page":"3694","DOI":"10.1210\/jc.2014-2267","article-title":"PTH(1\u201384) is associated with improved quality of life in hypoparathyroidism through 5 years of therapy","volume":"99","author":"Cusano","year":"2014","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.jocd.2017.01.001_bib0395","doi-asserted-by":"crossref","first-page":"1657","DOI":"10.1016\/S0140-6736(15)00728-X","article-title":"Osteogenesis imperfecta","volume":"387","author":"Forlino","year":"2016","journal-title":"Lancet"},{"key":"10.1016\/j.jocd.2017.01.001_bib0400","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1038\/nrendo.2011.81","article-title":"New perspectives on osteogenesis imperfecta","volume":"7","author":"Forlino","year":"2011","journal-title":"Nat Rev Endocrinol"},{"key":"10.1016\/j.jocd.2017.01.001_bib0405","doi-asserted-by":"crossref","first-page":"3095","DOI":"10.1210\/jc.2013-1505","article-title":"New genes in bone development: what's new in osteogenesis imperfecta","volume":"98","author":"Marini","year":"2013","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.jocd.2017.01.001_bib0410","first-page":"113","article-title":"Clinical variability in osteogenesis imperfecta\u2014variable expressivity or genetic heterogeneity","volume":"15","author":"Sillence","year":"1979","journal-title":"Birth Defects Orig Artic Ser"},{"key":"10.1016\/j.jocd.2017.01.001_bib0415","first-page":"24","article-title":"Safety and efficacy of denosumab in children with osteogenesis imperfecta\u2014a first prospective trial","volume":"16","author":"Hoyer-Kuhn","year":"2016","journal-title":"J Musculoskelet Neuronal Interact"},{"key":"10.1016\/j.jocd.2017.01.001_bib0420","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1186\/s13023-014-0145-1","article-title":"Two years' experience with denosumab for children with osteogenesis imperfecta type VI","volume":"9","author":"Hoyer-Kuhn","year":"2014","journal-title":"Orphanet J Rare Dis"},{"key":"10.1016\/j.jocd.2017.01.001_bib0425","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1172\/JCI71101","article-title":"Evaluation of teriparatide treatment in adults with osteogenesis imperfecta","volume":"124","author":"Orwoll","year":"2014","journal-title":"J Clin Invest"},{"key":"10.1016\/j.jocd.2017.01.001_bib0430","doi-asserted-by":"crossref","first-page":"2743","DOI":"10.1007\/s00198-015-3272-1","article-title":"Hypophosphatasia: an overview of the disease and its treatment","volume":"26","author":"Bianchi","year":"2015","journal-title":"Osteoporos Int"},{"key":"10.1016\/j.jocd.2017.01.001_bib0435","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1007\/s40265-015-0535-2","article-title":"Asfotase alfa: a review in paediatric-onset hypophosphatasia","volume":"76","author":"Scott","year":"2016","journal-title":"Drugs"},{"key":"10.1016\/j.jocd.2017.01.001_bib0440","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.mce.2016.05.008","article-title":"Update on FGF23 and Klotho signaling","volume":"432","author":"Erben","year":"2016","journal-title":"Mol Cell Endocrinol"},{"key":"10.1016\/j.jocd.2017.01.001_bib0445","doi-asserted-by":"crossref","first-page":"3388","DOI":"10.1210\/jc.2015-2391","article-title":"Iron supplementation associated with loss of phenotype in autosomal dominant hypophosphatemic rickets","volume":"100","author":"Kapelari","year":"2015","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.jocd.2017.01.001_bib0450","doi-asserted-by":"crossref","first-page":"1967","DOI":"10.1002\/jbmr.1642","article-title":"Tumor-induced osteomalacia: an important cause of adult-onset hypophosphatemic osteomalacia in China: report of 39 cases and review of the literature","volume":"27","author":"Jiang","year":"2012","journal-title":"J Bone Miner Res"},{"key":"10.1016\/j.jocd.2017.01.001_bib0455","doi-asserted-by":"crossref","first-page":"433","DOI":"10.5435\/JAAOS-D-14-00082","article-title":"Contemporary medical and surgical management of X-linked hypophosphatemic rickets","volume":"23","author":"Sharkey","year":"2015","journal-title":"J Am Acad Orthop Surg"},{"key":"10.1016\/j.jocd.2017.01.001_bib0460","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1007\/s11914-015-0259-y","article-title":"Hypophosphatemic rickets: lessons from disrupted FGF23 control of phosphorus homeostasis","volume":"13","author":"Goldsweig","year":"2015","journal-title":"Curr Osteoporos Rep"},{"key":"10.1016\/j.jocd.2017.01.001_bib0465","doi-asserted-by":"crossref","first-page":"1587","DOI":"10.1172\/JCI72829","article-title":"Randomized trial of the anti-FGF23 antibody KRN23 in X-linked hypophosphatemia","volume":"124","author":"Carpenter","year":"2014","journal-title":"J Clin Invest"},{"key":"10.1016\/j.jocd.2017.01.001_bib0470","doi-asserted-by":"crossref","first-page":"2565","DOI":"10.1210\/jc.2015-1551","article-title":"Prolonged correction of serum phosphorus in adults with X-linked hypophosphatemia using monthly doses of KRN23","volume":"100","author":"Imel","year":"2015","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.jocd.2017.01.001_bib0475","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1007\/s11914-016-0311-6","article-title":"Hajdu-Cheney syndrome, a disease associated with NOTCH2 mutations","volume":"14","author":"Canalis","year":"2016","journal-title":"Curr Osteoporos Rep"},{"key":"10.1016\/j.jocd.2017.01.001_bib0480","doi-asserted-by":"crossref","first-page":"2490","DOI":"10.1002\/ajmg.a.36656","article-title":"Prenatal and postnatal findings in serpentine fibula polycystic kidney syndrome and a review of the NOTCH2 spectrum disorders","volume":"164a","author":"Martin","year":"2014","journal-title":"Am J Med Genet A"},{"key":"10.1016\/j.jocd.2017.01.001_bib0485","doi-asserted-by":"crossref","first-page":"1114","DOI":"10.1002\/humu.21546","article-title":"Mutations in NOTCH2 in families with Hajdu-Cheney syndrome","volume":"32","author":"Majewski","year":"2011","journal-title":"Hum Mutat"},{"key":"10.1016\/j.jocd.2017.01.001_bib0490","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1038\/ng.779","article-title":"Mutations in NOTCH2 cause Hajdu-Cheney syndrome, a disorder of severe and progressive bone loss","volume":"43","author":"Simpson","year":"2011","journal-title":"Nat Genet"},{"key":"10.1016\/j.jocd.2017.01.001_bib0495","doi-asserted-by":"crossref","first-page":"2275","DOI":"10.1007\/s00198-013-2298-5","article-title":"Mutations in NOTCH2 in patients with Hajdu-Cheney syndrome","volume":"24","author":"Zhao","year":"2013","journal-title":"Osteoporos Int"},{"key":"10.1016\/j.jocd.2017.01.001_bib0500","doi-asserted-by":"crossref","first-page":"543","DOI":"10.3349\/ymj.2011.52.3.543","article-title":"Effect of zoledronic acid on acro-osteolysis and osteoporosis in a patient with Hajdu-Cheney syndrome","volume":"52","author":"Hwang","year":"2011","journal-title":"Yonsei Med J"},{"key":"10.1016\/j.jocd.2017.01.001_bib0505","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/j.beem.2014.08.010","article-title":"The clinical spectrum and pathophysiology of skeletal complications in lysosomal storage disorders","volume":"29","author":"Clarke","year":"2015","journal-title":"Best Pract Res Clin Endocrinol Metab"},{"key":"10.1016\/j.jocd.2017.01.001_bib0510","doi-asserted-by":"crossref","first-page":"153","DOI":"10.2106\/00004623-196749010-00015","article-title":"Pycnodysostosis: a review","volume":"49","author":"Elmore","year":"1967","journal-title":"J Bone Joint Surg Am"},{"key":"10.1016\/j.jocd.2017.01.001_bib0515","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.gene.2014.09.055","article-title":"Pycnodysostosis and the making of an artist","volume":"555","author":"Hodder","year":"2015","journal-title":"Gene"},{"key":"10.1016\/j.jocd.2017.01.001_bib0520","first-page":"109","article-title":"Pycnodysostosis, metabolic and histologic studies","volume":"5","author":"Soto","year":"1969","journal-title":"Birth Defects"},{"key":"10.1016\/j.jocd.2017.01.001_bib0525","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/j.jocd.2015.01.005","article-title":"DXA utilization between 2006 and 2012 in commercially insured younger postmenopausal women","volume":"18","author":"Overman","year":"2015","journal-title":"J Clin Densitom"},{"key":"10.1016\/j.jocd.2017.01.001_bib0530","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1016\/j.jocd.2015.06.013","article-title":"Executive summary of the 2015 ISCD Position Development Conference on advanced measures from DXA and QCT: fracture prediction beyond BMD","volume":"18","author":"Shepherd","year":"2015","journal-title":"J Clin Densitom"},{"key":"10.1016\/j.jocd.2017.01.001_bib0535","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1016\/j.jocd.2015.06.008","article-title":"Fracture risk prediction by non-BMD DXA measures: the 2015 ISCD Official Positions part 2: trabecular bone score","volume":"18","author":"Silva","year":"2015","journal-title":"J Clin Densitom"},{"key":"10.1016\/j.jocd.2017.01.001_bib0540","doi-asserted-by":"crossref","first-page":"940","DOI":"10.1002\/jbmr.2734","article-title":"A meta-analysis of trabecular bone score in fracture risk prediction and its relationship to FRAX","volume":"31","author":"McCloskey","year":"2016","journal-title":"J Bone Miner Res"},{"key":"10.1016\/j.jocd.2017.01.001_bib0545","doi-asserted-by":"crossref","first-page":"2467","DOI":"10.1007\/s00198-016-3550-6","article-title":"Trabecular bone scores and lumbar spine bone mineral density of US adults: comparison of relationships with demographic and body size variables","volume":"27","author":"Looker","year":"2016","journal-title":"Osteoporos Int"},{"key":"10.1016\/j.jocd.2017.01.001_bib0550","first-page":"S87","article-title":"Trabecular bone score (TBS) reference values from all combination of lumbar vertebrae in dual-energy absorptiometry (DXA) from NHANES 2005\u20132008 multiethnic Survey","volume":"31","author":"Fan","year":"2016","journal-title":"J Bone Miner Res"},{"key":"10.1016\/j.jocd.2017.01.001_bib0555","first-page":"393","article-title":"A statistical model of shape and bone mineral density distribution of the proximal femur for fracture risk assessment","volume":"14","author":"Whitmarsh","year":"2011","journal-title":"Med Image Comput Comput Assist Interv"},{"key":"10.1016\/j.jocd.2017.01.001_bib0560","doi-asserted-by":"crossref","first-page":"896","DOI":"10.1016\/j.bone.2012.08.114","article-title":"Hip fracture discrimination from dual-energy X-ray absorptiometry by statistical model registration","volume":"51","author":"Whitmarsh","year":"2012","journal-title":"Bone"},{"key":"10.1016\/j.jocd.2017.01.001_bib0565","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/j.media.2015.06.001","article-title":"Generation of 3D shape, density, cortical thickness and finite element mesh of proximal femur from a DXA image","volume":"24","author":"Vaananen","year":"2015","journal-title":"Med Image Anal"},{"key":"10.1016\/j.jocd.2017.01.001_bib0570","doi-asserted-by":"crossref","first-page":"2793","DOI":"10.1007\/s00198-015-3194-y","article-title":"Comparative performance of current definitions of sarcopenia against the prospective incidence of falls among community-dwelling seniors age 65 and older","volume":"26","author":"Bischoff-Ferrari","year":"2015","journal-title":"Osteoporos Int"},{"key":"10.1016\/j.jocd.2017.01.001_bib0575","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1007\/s40520-015-0494-1","article-title":"Osteosarcopenia is more than sarcopenia and osteopenia alone","volume":"28","author":"Drey","year":"2016","journal-title":"Aging Clin Exp Res"},{"key":"10.1016\/j.jocd.2017.01.001_bib0580","doi-asserted-by":"crossref","first-page":"1895","DOI":"10.3945\/ajcn.2008.26950","article-title":"Difficulties with physical function associated with obesity, sarcopenia, and sarcopenic-obesity in community-dwelling elderly women: the EPIDOS (EPIDemiologie de l'OSteoporose) Study","volume":"89","author":"Rolland","year":"2009","journal-title":"Am J Clin Nutr"},{"key":"10.1016\/j.jocd.2017.01.001_bib0585","doi-asserted-by":"crossref","first-page":"1414","DOI":"10.1002\/jbmr.2469","article-title":"Hip fractures risk in older men and women associated with DXA-derived measures of thigh subcutaneous fat thickness, cross-sectional muscle area, and muscle density","volume":"30","author":"Malkov","year":"2015","journal-title":"J Bone Miner Res"},{"key":"10.1016\/j.jocd.2017.01.001_bib0590","doi-asserted-by":"crossref","first-page":"1109","DOI":"10.1038\/oby.2011.367","article-title":"Dual-energy X-ray performs as well as clinical computed tomography for the measurement of visceral fat","volume":"20","author":"Micklesfield","year":"2012","journal-title":"Obesity (Silver Spring)"},{"key":"10.1016\/j.jocd.2017.01.001_bib0595","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0068716","article-title":"Ratio of trunk to leg volume as a new body shape metric for diabetes and mortality","volume":"8","author":"Wilson","year":"2013","journal-title":"PLoS ONE"},{"key":"10.1016\/j.jocd.2017.01.001_bib0600","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1016\/j.injury.2011.03.031","article-title":"The biology of fracture healing","volume":"42","author":"Marsell","year":"2011","journal-title":"Injury"},{"key":"10.1016\/j.jocd.2017.01.001_bib0605","first-page":"1259","article-title":"Effects of estrogen on fracture healing in mice","volume":"69","author":"Beil","year":"2010","journal-title":"J Trauma"},{"key":"10.1016\/j.jocd.2017.01.001_bib0610","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1007\/s00423-008-0436-x","article-title":"Estrogen and raloxifene improve metaphyseal fracture healing in the early phase of osteoporosis. A new fracture-healing model at the tibia in rat","volume":"395","author":"Stuermer","year":"2010","journal-title":"Langenbecks Arch Surg"},{"key":"10.1016\/j.jocd.2017.01.001_bib0615","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1007\/s00223-009-9318-7","article-title":"Do estrogen and alendronate improve metaphyseal fracture healing when applied as osteoporosis prophylaxis?","volume":"86","author":"Kolios","year":"2010","journal-title":"Calcif Tissue Int"},{"key":"10.1016\/j.jocd.2017.01.001_bib0620","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1016\/j.bone.2008.05.019","article-title":"Bolus or weekly zoledronic acid administration does not delay endochondral fracture repair but weekly dosing enhances delays in hard callus remodeling","volume":"43","author":"McDonald","year":"2008","journal-title":"Bone"},{"key":"10.1016\/j.jocd.2017.01.001_bib0625","doi-asserted-by":"crossref","first-page":"956","DOI":"10.1302\/0301-620X.94B7.29079","article-title":"Does early administration of bisphosphonate affect fracture healing in patients with intertrochanteric fractures?","volume":"94","author":"Kim","year":"2012","journal-title":"J Bone Joint Surg Br"},{"key":"10.1016\/j.jocd.2017.01.001_bib0630","doi-asserted-by":"crossref","first-page":"2329","DOI":"10.1007\/s00198-010-1473-1","article-title":"Association between timing of zoledronic acid infusion and hip fracture healing","volume":"22","author":"Colon-Emeric","year":"2011","journal-title":"Osteoporos Int"},{"key":"10.1016\/j.jocd.2017.01.001_bib0635","first-page":"38","article-title":"Pamidronate treatment of children with moderate-to-severe osteogenesis imperfecta: a note of caution","volume":"71","author":"Alharbi","year":"2009","journal-title":"Horm Res"},{"key":"10.1016\/j.jocd.2017.01.001_bib0640","doi-asserted-by":"crossref","first-page":"2044","DOI":"10.1359\/JBMR.050712","article-title":"Manipulation of the anabolic and catabolic responses with OP-1 and zoledronic acid in a rat critical defect model","volume":"20","author":"Little","year":"2005","journal-title":"J Bone Miner Res"},{"key":"10.1016\/j.jocd.2017.01.001_bib0645","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1359\/jbmr.081113","article-title":"Comparison of effects of the bisphosphonate alendronate versus the RANKL inhibitor denosumab on murine fracture healing","volume":"24","author":"Gerstenfeld","year":"2009","journal-title":"J Bone Miner Res"},{"key":"10.1016\/j.jocd.2017.01.001_bib0650","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1016\/j.bone.2010.05.013","article-title":"Effect of human parathyroid hormone hPTH (1\u201334) applied at different regimes on fracture healing and muscle in ovariectomized and healthy rats","volume":"47","author":"Komrakova","year":"2010","journal-title":"Bone"},{"key":"10.1016\/j.jocd.2017.01.001_bib0655","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1359\/jbmr.090731","article-title":"Teriparatide for acceleration of fracture repair in humans: a prospective, randomized, double-blind study of 102 postmenopausal women with distal radial fractures","volume":"25","author":"Aspenberg","year":"2010","journal-title":"J Bone Miner Res"},{"key":"10.1016\/j.jocd.2017.01.001_bib0660","doi-asserted-by":"crossref","first-page":"1583","DOI":"10.2106\/JBJS.J.01379","article-title":"Parathyroid hormone 1\u201384 accelerates fracture-healing in pubic bones of elderly osteoporotic women","volume":"93","author":"Peichl","year":"2011","journal-title":"J Bone Joint Surg Am"},{"key":"10.1016\/j.jocd.2017.01.001_bib0665","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.bone.2014.07.039","article-title":"Anti-DKK1 antibody promotes bone fracture healing through activation of beta-catenin signaling","volume":"71","author":"Jin","year":"2015","journal-title":"Bone"},{"key":"10.1016\/j.jocd.2017.01.001_bib0670","doi-asserted-by":"crossref","first-page":"1012","DOI":"10.1002\/jbmr.307","article-title":"Inhibition of sclerostin by monoclonal antibody enhances bone healing and improves bone density and strength of nonfractured bones","volume":"26","author":"Ominsky","year":"2011","journal-title":"J Bone Miner Res"},{"key":"10.1016\/j.jocd.2017.01.001_bib0675","doi-asserted-by":"crossref","first-page":"79","DOI":"10.2217\/whe.15.97","article-title":"Bone Health ECHO: telementoring to improve osteoporosis care","volume":"12","author":"Lewiecki","year":"2016","journal-title":"Womens Health (Lond)"},{"issue":"1","key":"10.1016\/j.jocd.2017.01.001_bib0680","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1007\/s00198-016-3708-2","article-title":"Telementoring: a novel approach to reducing the osteoporosis treatment gap","volume":"28","author":"Lewiecki","year":"2017","journal-title":"Osteoporos Int"}],"container-title":["Journal of Clinical Densitometry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1094695016302876?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1094695016302876?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T21:40:15Z","timestamp":1761082815000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1094695016302876"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,4]]},"references-count":135,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2017,4]]}},"alternative-id":["S1094695016302876"],"URL":"https:\/\/doi.org\/10.1016\/j.jocd.2017.01.001","relation":{},"ISSN":["1094-6950"],"issn-type":[{"value":"1094-6950","type":"print"}],"subject":[],"published":{"date-parts":[[2017,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Proceedings of the 2016 Santa Fe Bone Symposium: New Concepts in the Management of Osteoporosis and Metabolic Bone Diseases","name":"articletitle","label":"Article Title"},{"value":"Journal of Clinical Densitometry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jocd.2017.01.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Published by Elsevier Inc. on behalf of International Society for Clinical Densitometry.","name":"copyright","label":"Copyright"}]}}